Abstract:Exposure to early-in-life adversities represents one of the most relevant conditions linked to the etiology of mental disorders, characterized by emotional dysregulation. It is thought that changes in stress mediators or immune mechanisms during critical time windows may lead to structural and functional alterations in different brain circuits that underlie the manifestation of specific psychopathologic domains. The present symposium will summarize authoritatively recent advances in the functional mechanisms contributing to the etiology as well as to the manifestation of psychiatric disorders, with a specific focus on stress and immune dysfunction. The symposium will unfold upon the discussion of preclinical and clinical studies addressing different aspects related to psychiatric disorders. Prof. M.A. Riva (University of Milan, Italy) will show how exposure to prenatal stress (PNS) in rodents produces emotional dysregulation, characterized by reduced sociability and anxiety-like behavior in a percentage of adolescent offspring, whereas others appear to be resilient. Such vulnerability to PNS is associated with differences in the activity state of specific brain regions and with changes in the expression of immune and glucocorticoid- related markers. Along this line, Dr. A. Vernon (Kings College London, UK) will show that mouse offspring exposed to maternal immune activation could also be stratified into susceptible or resilient for multiple behavioral dysfunctions and that the neural correlates of susceptibility and resilience to MIA are best described using multivariate analysis of both neuroanatomical and behavioral data. More specifically, multivariate maps associated anxiety-like, social, cognitive, and sensorimotor gating deficits with volumes of multiple prefrontal and limbic grey matter regions and volumes of major white matter tracts. At the clinical level, childhood trauma has been linked with both stress-related disorders and auto-immune disorders, suggesting that inflammation represents both a mechanism and a target for the treatment of these disorders. With this regard, Dr. L. De Picker (University of Antwerp, Belgium) will discuss the endocrine and immunological pathways that are implicated in patients with childhood trauma and how they can result in increased vulnerability for mental disorders. Last, considering that stress and metabolic disturbances are thought to contribute to increased inflammation and effects on the brain and behavior in patients with depression and other psychiatric illnesses, Dr. J. Felger (Emory University, Atlanta, USA) will present new and published data showing relationships between stress and biomarkers of metabolic dysfunction, especially those related to lipid metabolism, and improvement in symptoms of anhedonia and deficits in reward circuit function in response to inflammation-targeted treatments in depression.

NIMH Activities: Vulnerability to Depressive and Schizophrenic Disorders--Conference Report

Aberrant Development of Cross-Frequency Multiplex Functional Connectome in First-Episode, Drug-Naive Major Depressive Disorder and Schizophrenia.

A neural model of vulnerability and resilience to stress-related disorders linked to differential susceptibility

Molecular, Functional, and Structural Imaging of Major Depressive Disorder

Vulnerability to Depression in Youth: Advances from Affective Neuroscience

Vulnerabilities in social anxiety: Integrating intra- and interpersonal perspectives

New insights into the neurobiological mechanisms of major depressive disorders

Cognitive and Neural Aspects of Information Processing in Major Depressive Disorder: An Integrative Perspective

Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models

Molecular and neural mechanisms of stress resilience and susceptibility

Cortical-Subcortical Interactions in Depression: From Animal Models to Human Psychopathology

Advancing Mental Health Research Through Strategic Integration of Transdiagnostic Dimensions and Genomics

Early life adversities in the etiology of mental illness: the role of immune mechanisms

Vulnerability and plasticity of monoamine neurotransmitter systems in affective and personality disorders

Annual Research Review: Neuroimmune network model of depression: a developmental perspective

Emotional and cognitive dysregulation in schizophrenia and depression: understanding common and distinct behavioral and neural mechanisms

The molecular neurobiology of depression

Pathogenesis of depression: Insights from human and rodent studies

Development and Natural History of Mood Disorders

Gene expression studies in Depression development and treatment: an overview of the underlying molecular mechanisms and biological processes to identify biomarkers

Cognitive correlates of hypothalamic–pituitary–adrenal axis in major depression